Cover Image
Market Research Report

North America Clinical Nutrition Market Forecast 2019-2028

Published by Inkwood Research Product code 952509
Published Content info 114 Pages
Delivery time: 2-3 business days
Price
Back to Top
North America Clinical Nutrition Market Forecast 2019-2028
Published: August 3, 2020 Content info: 114 Pages
Description

KEY FINDINGS

The North America clinical nutrition market is projected to evolve at a CAGR of 5.27% during the forecast period, 2019-2028. The continuous R&D activities, with regard to the development of innovative clinical nutrition, and the growing incidences of ischemic stroke, diabetes, coronary artery disease, etc. are set to drive the market growth.

MARKET INSIGHTS

The North America clinical nutrition market growth analysis entails the assessment of Canada and the United States. Preventive medical nutrition is being increasingly adopted by hospitals and clinics in North America. The coverage of universal healthcare in Canada is far more extensive in comparison to the United States. The country also recorded a higher consumption rate than the United States, with regard to the population versus unit consumption of clinical nutrition. Canada has a lower cost of clinical nutrition than that of the US, given its smaller population. It is a part of surgical procedures in Canada. More than 3% of the population turns 65 every year. The growing aging population and chronic illness conditions and the scope for clinical nutritional supplements are set to impact market growth. As of 2019, the annual per capita expenditure for dietary supplements in the country stood at $32.89. Such factors are set to put forth ample market growth opportunities in Canada.

COMPETITIVE INSIGHTS

Some of the qualified and well-established companies in the market are Exela Pharma Sciences, Lonza Ltd, Danone, Meiji Holdings Co Ltd, Grifols SA, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 32930

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. MARKET DEFINITION
  • 3.2. KEY DRIVERS
    • 3.2.1. INCREASING PREVALENCE OF CHRONIC DISEASES AND LIFESTYLE ASSOCIATED DISEASE
    • 3.2.2. RISE IN ELDERLY POPULATION
    • 3.2.3. HIGH OCCURRENCE OF MALNUTRITION AMONG HOSPITALIZED PATIENTS
  • 3.3. KEY RESTRAINTS
    • 3.3.1. LACK OF AWARENESS FOR CLINICAL NUTRITION
    • 3.3.2. COMPLICATIONS ASSOCIATED WITH ENTERAL FEEDING
    • 3.3.3. STRINGENT REGULATIONS

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCE ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. IMPACT OF COVID-19 ON CLINICAL NUTRITION MARKET
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY ROUTE OF ADMINISTRATION

  • 5.1. ORAL
  • 5.2. ENTERAL
  • 5.3. PARENTERAL

6. MARKET BY APPLICATION

  • 6.1. CANCER
  • 6.2. NEUROLOGICAL DISEASES
  • 6.3. GASTROINTESTINAL DISORDERS
  • 6.4. METABOLIC DISORDERS
  • 6.5. OTHER APPLICATIONS

7. MARKET BY END-USER

  • 7.1. PEDIATRIC
  • 7.2. GERIATRIC
  • 7.3. ADULTS

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. THE UNITED STATES
    • 8.1.2. CANADA

9. COMPANY PROFILES

  • 9.1. ABBOTT LABORATORIES
  • 9.2. AMERICAN REGENT INC
  • 9.3. BASF SE
  • 9.4. BAXTER INTERNATIONAL INC
  • 9.5. B. BRAUN
  • 9.6. DANONE
  • 9.7. EXELA PHARMA SCIENCES
  • 9.8. GRIFOLS SA
  • 9.9. LONZA LTD
  • 9.10. MEIJI HOLDINGS CO LTD
  • 9.11. NESTLE HEALTH SCIENCE
  • 9.12. OTSUKA HOLDINGS CO LTD
  • 9.13. RECKITT BENCKISER GROUP PLC
  • 9.14. SANOFI
  • 9.15. SICHUAN KELUN PHARMACEUTICAL CO LTD

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - CLINICAL NUTRITION
  • TABLE 2: NORTH AMERICA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 3: NORTH AMERICA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 4: NORTH AMERICA CLINICAL NUTRITION MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 5: NORTH AMERICA CLINICAL NUTRITION MARKET, BY APPLICATION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 6: NORTH AMERICA CLINICAL NUTRITION MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 7: NORTH AMERICA CLINICAL NUTRITION MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
  • TABLE 8: NORTH AMERICA CLINICAL NUTRITION MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
  • TABLE 9: NORTH AMERICA CLINICAL NUTRITION MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)

LIST OF FIGURES

  • FIGURE 1: MAJOR CATEGORIES OF NORTH AMERICA HEALTH SPENDING, 2017
  • FIGURE 2: COMPLICATIONS OF ENTERAL FEEDING
  • FIGURE 3: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 4: OPPORTUNITY MATRIX
  • FIGURE 5: VENDOR LANDSCAPE
  • FIGURE 6: KEY INVESTMENT INSIGHTS
  • FIGURE 7: NORTH AMERICA CLINICAL NUTRITION MARKET, BY ROUTE OF ADMINISTRATION, IN 2019
  • FIGURE 8: NORTH AMERICA CLINICAL NUTRITION MARKET, BY ORAL, 2019-2028 (IN $ MILLION)
  • FIGURE 9: NORTH AMERICA CLINICAL NUTRITION MARKET, BY ENTERAL, 2019-2028 (IN $ MILLION)
  • FIGURE 10: NORTH AMERICA CLINICAL NUTRITION MARKET, BY PARENTERAL, 2019-2028 (IN $ MILLION)
  • FIGURE 11: NORTH AMERICA CLINICAL NUTRITION MARKET, BY APPLICATION, IN 2019
  • FIGURE 12: NORTH AMERICA CLINICAL NUTRITION MARKET, BY CANCER, 2019-2028 (IN $ MILLION)
  • FIGURE 13: NORTH AMERICA CLINICAL NUTRITION MARKET, BY NEUROLOGICAL DISEASES, 2019-2028 (IN $ MILLION)
  • FIGURE 14: NORTH AMERICA CLINICAL NUTRITION MARKET, BY GASTROINTESTINAL DISORDERS, 2019-2028 (IN $ MILLION)
  • FIGURE 15: NORTH AMERICA CLINICAL NUTRITION MARKET, BY METABOLIC DISORDERS, 2019-2028 (IN $ MILLION)
  • FIGURE 16: NORTH AMERICA CLINICAL NUTRITION MARKET, BY OTHER APPLICATIONS, 2019-2028 (IN $ MILLION)
  • FIGURE 17: NORTH AMERICA CLINICAL NUTRITION MARKET, BY END-USER, IN 2019
  • FIGURE 18: NORTH AMERICA CLINICAL NUTRITION MARKET, BY PEDIATRIC, 2019-2028 (IN $ MILLION)
  • FIGURE 19: NORTH AMERICA CLINICAL NUTRITION MARKET, BY GERIATRIC, 2019-2028 (IN $ MILLION)
  • FIGURE 20: NORTH AMERICA CLINICAL NUTRITION MARKET, BY ADULTS, 2019-2028 (IN $ MILLION)
  • FIGURE 21: NORTH AMERICA CLINICAL NUTRITION MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)
  • FIGURE 22: THE UNITED STATES CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
  • FIGURE 23: CANADA CLINICAL NUTRITION MARKET, 2019-2028 (IN $ MILLION)
Back to Top